6-24701508-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018473.4(ACOT13):āc.316G>Cā(p.Val106Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018473.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACOT13 | NM_018473.4 | c.316G>C | p.Val106Leu | missense_variant | 3/3 | ENST00000230048.5 | |
ACOT13 | NM_001160094.2 | c.247G>C | p.Val83Leu | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACOT13 | ENST00000230048.5 | c.316G>C | p.Val106Leu | missense_variant | 3/3 | 1 | NM_018473.4 | P1 | |
ACOT13 | ENST00000537591.5 | c.247G>C | p.Val83Leu | missense_variant | 4/4 | 1 | |||
ENST00000607014.1 | n.286C>G | non_coding_transcript_exon_variant | 1/1 | ||||||
ACOT13 | ENST00000476436.1 | n.527G>C | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251270Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135808
GnomAD4 exome AF: 0.000229 AC: 334AN: 1461642Hom.: 0 Cov.: 30 AF XY: 0.000246 AC XY: 179AN XY: 727122
GnomAD4 genome AF: 0.000171 AC: 26AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.316G>C (p.V106L) alteration is located in exon 3 (coding exon 3) of the ACOT13 gene. This alteration results from a G to C substitution at nucleotide position 316, causing the valine (V) at amino acid position 106 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at